Work

Epstein Barr Virus–Negative Lymphoplasmacytic Proliferation Limited to the Renal Allograft: A Unique Presentation of a Rare Disease

Year: 2021

Type: article

Abstract: Posttransplant lymphoma, classified as posttransplant lymphoproliferative disorder (PTLD) in the majority of cases, affects 1% to 3% of kidney transplant recipients and is associated with significant morbidity and mortality.1,2 The clinical presentation is variable, ranging from 1 site to multiorgan disease. Renal allograft involvement is seen in as many as 13% of recipients with histologic features of predominantly monomorphic or polymorphic B-cell proliferation.3 Posttransplant lymphoma presenting as plasmacytic infiltration confined to an allograft has been described in few cases.

Source: Kidney International Reports

DOI: 10.1016/j.ekir.2021.05.024